Company Filing History:
Years Active: 2017
Title: Michael Dziegelewski: Innovator in Anti-BAFF Antibodies
Introduction
Michael Dziegelewski is a notable inventor based in Newburgh, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Michael Dziegelewski holds a patent for anti-BAFF antibodies. The present invention relates to anti-BAFF antibody molecules, including novel humanized anti-BAFF antibodies, therapeutic and diagnostic methods, and compositions for using the same. This patent represents a significant advancement in the treatment of diseases related to B-cell activation.
Career Highlights
Michael is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development in the field of therapeutic antibodies, where he applies his expertise to create innovative solutions for patient care.
Collaborations
Some of his notable coworkers include Scott Ronald Brodeur and Keith Allen Canada. Their collaborative efforts contribute to the advancement of research and development in the biotechnology sector.
Conclusion
Michael Dziegelewski's work in anti-BAFF antibodies exemplifies the impact of innovation in biotechnology. His contributions are paving the way for new therapeutic options that can improve patient outcomes.